What is NHC's health score?

NATIONAL HEALTHCARE CORP (NHC) has a TradeApes health score of 59 out of 100, rated Mixed. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is NHC's estimated fair value?

Based on our 5-year discounted cash flow model, NATIONAL HEALTHCARE CORP's estimated fair value is $N/A per share. This is a model estimate, not a price target or investment recommendation.

Is NHC undervalued or overvalued?

Our model currently rates NHC as Overvalued. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

To Unlock Full Report

3 free score cards remaining

NATIONAL HEALTHCARE CORP (NHC)

Healthcare Overvalued low mixed

$228.16

Updated: 2026-07-18

TradeApes Score

Financial Strength

80 Strong

Operating Trend

50 Mixed

Relative Value

40 Weak

Capital Allocation

55 Mixed

Risk Management

80 Strong

Key Findings

+ Low leverage — net debt/EBITDA below 1×

Unlock Full Report →

− High P/E — 25–45×, growth premium already priced in

Unlock Full Report →

Industry Related Stocks

AGILENT TECHNOLOGIES, INC. (A) ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG) Aardvark Therapeutics, Inc. (AARD) AUTOSCOPE TECHNOLOGIES CORP (AATC) Abivax S.A. (AAVXF) Ascend Wellness Holdings, Inc. (AAWH)

See all Healthcare stocks →

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.